What is Arthromeda?
Arthromeda operates at the intersection of medical device engineering and digital health, specializing in patient-specific solutions that enhance the accuracy of arthroplasty surgery. The company's core value proposition centers on the integration of micro-sensors, wireless connectivity, and proprietary software to optimize orthopedic implant alignment. Through flagship offerings such as ArthroSight-PS, a real-time micro-sensor platform for hip procedures, and ArthroPlan, a cloud-based digital templating suite, Arthromeda addresses the critical need for precision in joint replacement. By reducing the incidence of implant revisions, the company provides a compelling economic and clinical argument for healthcare providers seeking to modernize their surgical workflows and improve long-term patient outcomes in an increasingly competitive orthopedic market.
How much funding has Arthromeda raised?
Arthromeda has raised a total of $11.8M across 2 funding rounds:
Debt
$3.2M
Stock/Share Issuance
$8.6M
Debt (2025): $3.2M, investors not publicly disclosed
Stock/Share Issuance (2026): $8.6M, investors not publicly disclosed
Key Investors in Arthromeda
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Arthromeda?
With the recent infusion of capital, Arthromeda is poised to scale its operational footprint and deepen its penetration within the global orthopedic market. The strategic roadmap likely involves expanding the clinical validation of its sensor-based platforms and enhancing the interoperability of its cloud-based software with existing hospital information systems. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward broader commercial adoption and the potential development of new diagnostic modules. By maintaining its commitment to precision-driven surgical innovation, Arthromeda is set to influence the future of joint replacement, potentially setting new benchmarks for efficiency and patient safety in the orthopedic sector.
See full Arthromeda company page
